Press Release Awards

Endocrine Society congratulates 2021 Early Investigators Award winners

Washington, DC March 17, 2021

The Endocrine Society has selected five recipients for its Early Investigators Awards.

The Early Investigators Awards were established to assist in the development of early career investigators and to recognize their accomplishments in endocrine-related research.

The Endocrine Society’s 2021 Early Investigators Award winners are:

  • Himanshu Arora, Ph.D., of the University of Miami in Coral Gables, Fla. Arora’s lab focuses on exploring the therapeutic efficacy of immunotherapy against different stages of prostate cancer and using machine learning tools to study the progression of the cancer.
  • Ana Aulinas, M.D., Ph.D., of the Hospital de Sant Pau in Barcelona, Spain. Her research focuses on neuroendocrinology, hypothalamic and pituitary diseases. Aulinas seeks to improve outcomes in patients with pituitary diseases through her research, clinical work and teaching.
  • Athanasios Bikas, M.D., Ph.D., of Brigham and Women's Hospital in Boston, Mass. Bikas pursued a post-graduate research fellowship in thyroid cancer. He has published several papers in high impact journals like The Journal of Clinical Endocrinology & Metabolism and Thyroid.
  • Juan Brito, M.D., of the Mayo Clinic in Rochester, Minn. Brito serves as a guideline methodologist for the Endocrine Society’s Clinical Practice Guidelines. He has authored more than 140 peer-reviewed manuscripts. His research focuses on thyroid cancer and its overtreatment and the use of levothyroxine in the United States.
  • Manuel D. Gahete, Ph.D., of the University of Cordoba in Andalusia, Spain. Gahete’s research focuses on identifying novel molecules that could be used as diagnostic, prognostic and/or therapeutic markers for endocrine cancers and diseases such as obesity and diabetes.  

Recipients received a monetary award, one-year complimentary membership to the Society, one-year complimentary access to the Society's online journals, and public recognition of research accomplishments in various Society platforms.

Additional information on this award and the recipients is located on the Society’s website at https://www.endocrine.org/awards/early-investigators-awards.

The new application cycle opens in September 2021. 

About Endocrine Society

Endocrinologists are at the core of solving the most pressing health problems of our time, from diabetes and obesity to infertility, bone health, and hormone-related cancers. The Endocrine Society is the world’s oldest and largest organization of scientists devoted to hormone research and physicians who care for people with hormone-related conditions.

The Society has more than 18,000 members, including scientists, physicians, educators, nurses, and students in 122 countries. To learn more about the Society and the field of endocrinology, visit our site at www.endocrine.org. Follow us on X (formerly Twitter) at @TheEndoSociety and @EndoMedia.

Media Contacts

Colleen Williams Senior Communications Manager, Public Relations Phone: (202)-971-3611 [email protected]

Jenni Glenn Gingery Director, Communications and Media Relations Phone: (202)-971-3655 [email protected]

All News & Advocacy

Hill Event
Podcast

Endocrine News Podcast

EndocrineNewsPodcast
The Endocrine News podcast brings you the latest research and clinical advances from experts in the field, whether you are in your car, office, or out for a run.

The Endocrine News podcast brings you the latest research and clinical advances from experts in the field, whether you are in your car, office, or out for a run.

Bench to Bedside

Endocrine Society Journals

Research
Our top-ranked peer-reviewed journals are among the first to publish major developments and discovery milestones.

Our top-ranked peer-reviewed journals are among the first to publish major developments and discovery milestones.

Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.